We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Amazon Funds Columbia University Trial of Plasma Therapy for COVID-19

Amazon Funds Columbia University Trial of Plasma Therapy for COVID-19

IV patient and doctor
April 27, 2020

Amazon gave Columbia University $2.5 million to fund its clinical trial of a possible plasma therapy for the treatment of COVID-19.

The university’s Center for Infection and Immunity is conducting the trial to determine if plasma from COVID-19 survivors can be used to prevent infections and whether it can treat severe COVID-19 patients.

The trial will involve 450 individuals, including close contacts of COVID-19 patients, healthcare workers and intensive care unit patients.

View today's stories

Pharmaceuticals COVID-19 Research and Development

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 17May

    CDER’s Priorities for 2022: What You Must Know About New Guidance and Program Plans

  • 18May

    FDA’s New Distributor Licensing Standards: What Manufacturers, Wholesale Distributors and Third-Party Logistics Providers Must Know

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 21Jun

    Medical Device Reporting: Best Practices and Common Pitfalls

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • FDA Grants 510(k) Clearance to iSono Health's Atusa Wearable 3D Breast Ultrasound

  • FDA Approves Mitsubishi Tanabe Oral Form of Radicava for ALS

  • Philips Gains FDA’s 510(k) Clearance for Its MR 7700 Diagnostic System

  • Sanofi Ordered to Pay More Than $400,000 to Family Over Depakine Side Effects

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing